Breaking News Instant updates and real-time market news.

ACB

Aurora Cannabis

$4.40 /

-0.275 (-5.88%)

09:32
10/27/20
10/27
09:32
10/27/20
09:32

Aurora Cannabis downgraded to Neutral from Overweight at Cantor Fitzgerald

Cantor Fitzgerald analyst Pablo Zuanic downgraded Aurora Cannabis to Neutral from Overweight with a price target of C$7, down from C$18. While the analyst had been Overweight on overall market tailwinds and expected portfolio adjustments, Zuanic says today's disclosure the company used what was left of the $183M equity facility in the last 30 days is contrary to expectations and guidance. Additionally, the analyst says balance sheet constraints are likely to prevent the company from benefiting from potential regulatory changes in the U.S.

ACB Aurora Cannabis
$4.40 /

-0.275 (-5.88%)

10/27/20 Cantor Fitzgerald
Aurora Cannabis downgraded to Neutral from Overweight at Cantor Fitzgerald
09/24/20 CIBC
Aurora Cannabis price target lowered to C$12 from C$20 at CIBC
09/23/20 MKM Partners
Aurora Cannabis price target lowered to C$9 from C$18 at MKM Partners
09/23/20 Piper Sandler
Aurora Cannabis price target lowered to $8 from $10 at Piper Sandler

TODAY'S FREE FLY STORIES

Hot Stocks
Landos Biopharma says all endpoints in Phase 1 study of NX-13 met » 07:28
03/04/21
03/04
07:28
03/04/21
07:28
LABP

Landos Biopharma

$15.22 /

+0.73 (+5.04%)

Landos Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LABP Landos Biopharma
$15.22 /

+0.73 (+5.04%)

LABP Landos Biopharma
$15.22 /

+0.73 (+5.04%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
  • 04
    Feb
LABP Landos Biopharma
$15.22 /

+0.73 (+5.04%)

Downgrade
Regency Centers downgraded to Hold from Buy at Argus » 07:27
03/04/21
03/04
07:27
03/04/21
07:27
REG

Regency Centers

$56.67 /

+2.525 (+4.66%)

Argus analyst Jacob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REG Regency Centers
$56.67 /

+2.525 (+4.66%)

REG Regency Centers
$56.67 /

+2.525 (+4.66%)

01/25/21 Compass Point
Regency Centers upgraded to Buy from Neutral at Compass Point
12/30/20 Truist
Regency Centers price target raised to $50 from $45 at Truist
08/19/20
Fly Intel: Top five analyst downgrades
08/19/20 Compass Point
Compass Point downgrades Regency Centers on 'tactical valuation call'
REG Regency Centers
$56.67 /

+2.525 (+4.66%)

REG Regency Centers
$56.67 /

+2.525 (+4.66%)

Hot Stocks
NewAge enters LOI to acquire Japan-based Aliven for approx. 1M shares » 07:26
03/04/21
03/04
07:26
03/04/21
07:26
NBEV

NewAge

$2.82 /

-0.1 (-3.43%)

NewAge announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NBEV NewAge
$2.82 /

-0.1 (-3.43%)

NBEV NewAge
$2.82 /

-0.1 (-3.43%)

07/21/20 Alliance Global Partners
New Age Beverages price target raised to $5 from $3.50 at Alliance Global
04/14/20 Alliance Global Partners
New Age Beverages at Alliance Global Partners
03/11/20 Compass Point
New Age Beverages price target lowered to $4 from $9 at Compass Point
NBEV NewAge
$2.82 /

-0.1 (-3.43%)

NBEV NewAge
$2.82 /

-0.1 (-3.43%)

Recommendations
Main Street price target raised to $40 from $34 at RBC Capital » 07:25
03/04/21
03/04
07:25
03/04/21
07:25
MAIN

Main Street

$37.33 /

+0.63 (+1.72%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAIN Main Street
$37.33 /

+0.63 (+1.72%)

MAIN Main Street
$37.33 /

+0.63 (+1.72%)

08/12/20 Truist
Main Street price target raised to $33 from $28 at Truist
04/15/20 National Securities
Main Street downgraded to Neutral from Buy at National Securities
03/17/20 National Securities
Main Street upgraded to Buy from Neutral at National Securities
MAIN Main Street
$37.33 /

+0.63 (+1.72%)

Recommendations
Exxon Mobil price target raised to $60 from $57 at Morgan Stanley » 07:25
03/04/21
03/04
07:25
03/04/21
07:25
XOM

Exxon Mobil

$56.52 /

+0.45 (+0.80%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

07:13 Today Truist
Exxon Mobil price target raised to $60 from $50 at Truist
06:14 Today Citi
Exxon Mobil price target raised to $53 from $44 at Citi
03/02/21 Wells Fargo
Exxon Mobil price target raised to $65 from $53 at Wells Fargo
02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

Hot Stocks
VBL Therapeutics announces publication of interim analysis of OVAL study » 07:24
03/04/21
03/04
07:24
03/04/21
07:24
VBLT

VBL Therapeutics

$1.83 /

-0.12 (-6.15%)

VBL Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VBLT VBL Therapeutics
$1.83 /

-0.12 (-6.15%)

VBLT VBL Therapeutics
$1.83 /

-0.12 (-6.15%)

01/28/21 H.C. Wainwright
VBL Therapeutics price target raised to $4 from $3 at H.C. Wainwright
VBLT VBL Therapeutics
$1.83 /

-0.12 (-6.15%)

VBLT VBL Therapeutics
$1.83 /

-0.12 (-6.15%)

Hot Stocks
Fulcrum Therapeutics CEO Robert Gould to retire, Bryan Stuart to succeed » 07:23
03/04/21
03/04
07:23
03/04/21
07:23
FULC

Fulcrum Therapeutics

$14.59 /

+0.59 (+4.21%)

Fulcrum Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

03/01/21 Stifel
Fulcrum Therapeutics initiated with a Buy at Stifel
10/15/20 Piper Sandler
Fulcrum Therapeutics initiated with an Overweight at Piper Sandler
08/12/20
Fly Intel: Top five analyst downgrades
08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

  • 20
    Jan
Recommendations
General Electric price target raised to $17 from $13 at Morgan Stanley » 07:22
03/04/21
03/04
07:22
03/04/21
07:22
GE

General Electric

$13.45 /

+0.48 (+3.70%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GE General Electric
$13.45 /

+0.48 (+3.70%)

GE General Electric
$13.45 /

+0.48 (+3.70%)

03/02/21 Barclays
Danaher started at Overweight at Barclays on GE biopharma business potential
02/22/21 Goldman Sachs
General Electric price target raised to $15 at Goldman Sachs after meetings
01/28/21 Barclays
General Electric price target raised to $13 from $12 at Barclays
01/27/21 Morgan Stanley
General Electric price target raised to $13 from $12 at Morgan Stanley
GE General Electric
$13.45 /

+0.48 (+3.70%)

GE General Electric
$13.45 /

+0.48 (+3.70%)

GE General Electric
$13.45 /

+0.48 (+3.70%)

GE General Electric
$13.45 /

+0.48 (+3.70%)

Hot Stocks
DeepGreen Metals enters $2.9B combination agreement with SOAC » 07:22
03/04/21
03/04
07:22
03/04/21
07:22
SOAC

Sustainable Opportunities Acquisition Corp.

$10.22 /

-0.2 (-1.92%)

DeepGreen Metals …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SOAC Sustainable Opportunities Acquisition Corp.
$10.22 /

-0.2 (-1.92%)

SOAC Sustainable Opportunities Acquisition Corp.
$10.22 /

-0.2 (-1.92%)

Hot Stocks
Kronos Bio to initiate Phase 3 trial of entospletinib in mid-2021 » 07:21
03/04/21
03/04
07:21
03/04/21
07:21
KRON

Kronos Bio

$28.75 /

-0.66 (-2.24%)

Kronos Bio announced,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRON Kronos Bio
$28.75 /

-0.66 (-2.24%)

KRON Kronos Bio
$28.75 /

-0.66 (-2.24%)

11/03/20
Fly Intel: Top five analyst initiations
11/03/20 Jefferies
Kronos Bio initiated with a Buy at Jefferies
11/03/20 Piper Sandler
Kronos Bio initiated with an Overweight at Piper Sandler
11/03/20 Goldman Sachs
Kronos Bio initiated with a Buy at Goldman Sachs
KRON Kronos Bio
$28.75 /

-0.66 (-2.24%)

  • 09
    Oct
KRON Kronos Bio
$28.75 /

-0.66 (-2.24%)

KRON Kronos Bio
$28.75 /

-0.66 (-2.24%)

Hot Stocks
Sol-Gel Technologies expects cash to fund requirements into 3Q22 » 07:20
03/04/21
03/04
07:20
03/04/21
07:20
SLGL

Sol-Gel Technologies

$9.58 /

-0.05 (-0.52%)

As of December 31, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLGL Sol-Gel Technologies
$9.58 /

-0.05 (-0.52%)

SLGL Sol-Gel Technologies
$9.58 /

-0.05 (-0.52%)

03/26/20 H.C. Wainwright
Sol-Gel Technologies price target lowered to $21 from $26 at H.C. Wainwright
SLGL Sol-Gel Technologies
$9.58 /

-0.05 (-0.52%)

SLGL Sol-Gel Technologies
$9.58 /

-0.05 (-0.52%)

Hot Stocks
Shift4 Payments announces acquisition of VenueNext, terms undisclosed » 07:19
03/04/21
03/04
07:19
03/04/21
07:19
FOUR

Shift4 Payments

$71.06 /

-4.24 (-5.63%)

Shift4 Payments announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

01/06/21 Wolfe Research
Shift4 Payments downgraded to Peer Perform from Outperform at Wolfe Research
01/06/21 BofA
Shift4 Payments double-downgraded to Underperform from Buy at BofA
12/21/20
Fly Intel: Top five analyst initiations
12/21/20 Piper Sandler
Shift4 Payments initiated with an Overweight at Piper Sandler
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

  • 03
    Dec
  • 11
    Sep
  • 05
    Jun
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

Earnings
Sol-Gel Technologies reports 2020 EPS ($1.30), consensus ($1.48) » 07:19
03/04/21
03/04
07:19
03/04/21
07:19
SLGL

Sol-Gel Technologies

$9.58 /

-0.05 (-0.52%)

Reports 2020 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLGL Sol-Gel Technologies
$9.58 /

-0.05 (-0.52%)

SLGL Sol-Gel Technologies
$9.58 /

-0.05 (-0.52%)

03/26/20 H.C. Wainwright
Sol-Gel Technologies price target lowered to $21 from $26 at H.C. Wainwright
SLGL Sol-Gel Technologies
$9.58 /

-0.05 (-0.52%)

SLGL Sol-Gel Technologies
$9.58 /

-0.05 (-0.52%)

Downgrade
Retail Properties of America downgraded to Sector Weight at KeyBanc » 07:18
03/04/21
03/04
07:18
03/04/21
07:18
RPAI

Retail Properties of America

$10.99 /

+0.51 (+4.87%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPAI Retail Properties of America
$10.99 /

+0.51 (+4.87%)

RPAI Retail Properties of America
$10.99 /

+0.51 (+4.87%)

05:20 Today KeyBanc
Retail Properties downgraded to Sector Weight from Overweight at KeyBanc
12/15/20 Citi
Retail Properties of America price target raised to $9.50 from $7 at Citi
11/10/20 Compass Point
Compass Point upgrades four retail REITs to Neutral after Pfizer 'game changer'
11/09/20 Compass Point
Retail Properties of America upgraded to Neutral from Sell at Compass Point
RPAI Retail Properties of America
$10.99 /

+0.51 (+4.87%)

Hot Stocks
Fulcrum Therapeutics expects cash to fund requirements into 4Q22 » 07:16
03/04/21
03/04
07:16
03/04/21
07:16
FULC

Fulcrum Therapeutics

$14.59 /

+0.59 (+4.21%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

03/01/21 Stifel
Fulcrum Therapeutics initiated with a Buy at Stifel
10/15/20 Piper Sandler
Fulcrum Therapeutics initiated with an Overweight at Piper Sandler
08/12/20
Fly Intel: Top five analyst downgrades
08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

  • 20
    Jan
Upgrade
Site Centers upgraded to Overweight at KeyBanc » 07:16
03/04/21
03/04
07:16
03/04/21
07:16
SITC

Site Centers

$12.89 /

+0.1 (+0.78%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SITC Site Centers
$12.89 /

+0.1 (+0.78%)

SITC Site Centers
$12.89 /

+0.1 (+0.78%)

05:19 Today KeyBanc
Site Centers upgraded to Overweight from Sector Weight at KeyBanc
02/23/21 Mizuho
Site Centers price target raised to $13 from $10.50 at Mizuho
01/14/21 Piper Sandler
Site Centers upgraded to Overweight from Neutral at Piper Sandler
12/15/20 Citi
Site Centers price target raised to $11 from $8.50 at Citi
SITC Site Centers
$12.89 /

+0.1 (+0.78%)

  • 02
    Mar
Hot Stocks
Fulcrum Therapeutics decides to discontinue LOSVID Phase 3 trial » 07:16
03/04/21
03/04
07:16
03/04/21
07:16
FULC

Fulcrum Therapeutics

$14.59 /

+0.59 (+4.21%)

After careful…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

03/01/21 Stifel
Fulcrum Therapeutics initiated with a Buy at Stifel
10/15/20 Piper Sandler
Fulcrum Therapeutics initiated with an Overweight at Piper Sandler
08/12/20
Fly Intel: Top five analyst downgrades
08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

  • 20
    Jan
Initiation
Wheaton Precious Metals initiated with an Overweight at JPMorgan » 07:16
03/04/21
03/04
07:16
03/04/21
07:16
WPM

Wheaton Precious Metals

$35.82 /

-1.05 (-2.85%)

JPMorgan analyst Tyler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WPM Wheaton Precious Metals
$35.82 /

-1.05 (-2.85%)

WPM Wheaton Precious Metals
$35.82 /

-1.05 (-2.85%)

03/01/21 Berenberg
Wheaton Precious Metals price target raised to 3,700 GBp at Berenberg
02/16/21 Berenberg
Wheaton Precious Metals price target lowered to 3,500 GBp from 3,700 GBp at Berenberg
02/08/21 Stifel
Wheaton Precious Metals upgraded to Buy from Hold at Stifel
02/02/21 Credit Suisse
Wheaton Precious Metals price target lowered to C$62 from C$64 at Credit Suisse
WPM Wheaton Precious Metals
$35.82 /

-1.05 (-2.85%)

WPM Wheaton Precious Metals
$35.82 /

-1.05 (-2.85%)

WPM Wheaton Precious Metals
$35.82 /

-1.05 (-2.85%)

WPM Wheaton Precious Metals
$35.82 /

-1.05 (-2.85%)

Earnings
Fulcrum Therapeutics reports Q4 EPS (64c), consensus (72c) » 07:15
03/04/21
03/04
07:15
03/04/21
07:15
FULC

Fulcrum Therapeutics

$14.59 /

+0.59 (+4.21%)

Reports Q4 revenue $4.2M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

03/01/21 Stifel
Fulcrum Therapeutics initiated with a Buy at Stifel
10/15/20 Piper Sandler
Fulcrum Therapeutics initiated with an Overweight at Piper Sandler
08/12/20
Fly Intel: Top five analyst downgrades
08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
FULC Fulcrum Therapeutics
$14.59 /

+0.59 (+4.21%)

  • 20
    Jan
Hot Stocks
Gol Linhas reports preliminary February traffic down 50.3% » 07:15
03/04/21
03/04
07:15
03/04/21
07:15
GOL

Gol Linhas

$7.32 /

-0.03 (-0.41%)

Reports preliminary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOL Gol Linhas
$7.32 /

-0.03 (-0.41%)

GOL Gol Linhas
$7.32 /

-0.03 (-0.41%)

01/28/21 Deutsche Bank
Gol Linhas downgraded to Hold on slowing recovery at Deutsche Bank
01/28/21 Deutsche Bank
Gol Linhas downgraded to Hold from Buy at Deutsche Bank
01/12/21 Deutsche Bank
Gol Linhas price target raised to $15 from $10 at Deutsche Bank
12/21/20 Santander
Gol Linhas downgraded to Hold from Buy at Santander
GOL Gol Linhas
$7.32 /

-0.03 (-0.41%)

GOL Gol Linhas
$7.32 /

-0.03 (-0.41%)

GOL Gol Linhas
$7.32 /

-0.03 (-0.41%)

Earnings
Schrodinger sees FY21 revenue $124M-$142M, consensus $177.25M » 07:15
03/04/21
03/04
07:15
03/04/21
07:15
SDGR

Schrodinger

$99.03 /

-7.82 (-7.32%)

Sees FY21 software…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SDGR Schrodinger
$99.03 /

-7.82 (-7.32%)

SDGR Schrodinger
$99.03 /

-7.82 (-7.32%)

01/25/21 BMO Capital
Schrodinger price target raised to $117 from $97 at BMO Capital
11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/23/20 BofA
Schrodinger upgraded to Buy from Neutral at BofA
10/12/20 Jefferies
Schrodinger upgraded to Buy from Hold at Jefferies
SDGR Schrodinger
$99.03 /

-7.82 (-7.32%)

  • 13
    Aug
SDGR Schrodinger
$99.03 /

-7.82 (-7.32%)

SDGR Schrodinger
$99.03 /

-7.82 (-7.32%)

Initiation
Royal Gold initiated with an Overweight at JPMorgan » 07:14
03/04/21
03/04
07:14
03/04/21
07:14
RGLD

Royal Gold

$103.58 /

-2.95 (-2.77%)

JPMorgan analyst Tyler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RGLD Royal Gold
$103.58 /

-2.95 (-2.77%)

RGLD Royal Gold
$103.58 /

-2.95 (-2.77%)

07:12 Today JPMorgan
Franco-Nevada initiated with a Neutral at JPMorgan
01/11/21 RBC Capital
Royal Gold upgraded to Outperform from Sector Perform at RBC Capital
01/11/21 RBC Capital
Royal Gold upgraded to Outperform from Sector Perform at RBC Capital
11/23/20 Canaccord
Royal Gold upgraded to Buy from Hold at Canaccord
RGLD Royal Gold
$103.58 /

-2.95 (-2.77%)

Upgrade
Kite Realty Group upgraded to Overweight at KeyBanc » 07:14
03/04/21
03/04
07:14
03/04/21
07:14
KRG

Kite Realty Group

$19.46 /

+0.31 (+1.62%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRG Kite Realty Group
$19.46 /

+0.31 (+1.62%)

KRG Kite Realty Group
$19.46 /

+0.31 (+1.62%)

05:20 Today KeyBanc
Kite Realty Group upgraded to Overweight from Sector Weight at KeyBanc
12/10/20 Wells Fargo
Kite Realty Group upgraded to Overweight at Wells Fargo
12/10/20 Wells Fargo
Kite Realty Group upgraded to Overweight from Equal Weight at Wells Fargo
08/19/20
Fly Intel: Top five analyst downgrades
KRG Kite Realty Group
$19.46 /

+0.31 (+1.62%)

Hot Stocks
VYNE Therapeutics expects cash to fund requirements through end of 2022 » 07:14
03/04/21
03/04
07:14
03/04/21
07:14
VYNE

VYNE Therapeutics

$7.38 /

+0.1 (+1.37%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VYNE VYNE Therapeutics
$7.38 /

+0.1 (+1.37%)

VYNE VYNE Therapeutics
$7.38 /

+0.1 (+1.37%)

10/05/20 H.C. Wainwright
VYNE Therapeutics price target raised to $3.50 from $3 at H.C. Wainwright
VYNE VYNE Therapeutics
$7.38 /

+0.1 (+1.37%)

VYNE VYNE Therapeutics
$7.38 /

+0.1 (+1.37%)

Recommendations
Exxon Mobil price target raised to $60 from $50 at Truist » 07:13
03/04/21
03/04
07:13
03/04/21
07:13
XOM

Exxon Mobil

$56.52 /

+0.45 (+0.80%)

Truist analyst Welles…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

06:14 Today Citi
Exxon Mobil price target raised to $53 from $44 at Citi
03/02/21 Wells Fargo
Exxon Mobil price target raised to $65 from $53 at Wells Fargo
02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

XOM Exxon Mobil
$56.52 /

+0.45 (+0.80%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.